Susquehanna International Group, LLP Bio Rad Laboratories, Inc. Transaction History

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 7,361 shares of BIO stock, worth $2.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,361
Previous 11,166 34.08%
Holding current value
$2.19 Million
Previous $2.72 Million 34.68%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$216.56 - $256.68 $824,010 - $976,667
-3,805 Reduced 34.08%
7,361 $1.78 Million
Q1 2025

May 14, 2025
BUY
$243.0 - $367.0 $1.8 Million - $2.72 Million
7,411 Added 197.36%
11,166 $2.72 Million
Q4 2024

Feb 14, 2025
SELL
$313.15 - $374.28 $8.74 Million - $10.4 Million
-27,910 Reduced 88.14%
3,755 $1.23 Million
Q3 2024

Nov 14, 2024
BUY
$263.97 - $344.64 $5.36 Million - $7 Million
20,304 Added 178.72%
31,665 $10.6 Million
Q2 2024

Aug 15, 2024
SELL
$268.26 - $339.48 $136,544 - $172,795
-509 Reduced 4.29%
11,361 $3.1 Million
Q1 2024

May 07, 2024
BUY
$304.11 - $351.99 $1.74 Million - $2.01 Million
5,709 Added 92.66%
11,870 $4.11 Million
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $4.79 Million - $6.49 Million
-17,777 Reduced 74.26%
6,161 $1.99 Million
Q3 2023

Nov 14, 2023
BUY
$350.25 - $422.63 $4.87 Million - $5.88 Million
13,911 Added 138.74%
23,938 $8.58 Million
Q2 2023

Aug 11, 2023
SELL
$359.49 - $486.4 $933,595 - $1.26 Million
-2,597 Reduced 20.57%
10,027 $3.8 Million
Q1 2023

May 16, 2023
BUY
$418.69 - $503.0 $1.43 Million - $1.72 Million
3,427 Added 37.26%
12,624 $6.05 Million
Q4 2022

Feb 14, 2023
BUY
$351.71 - $456.01 $2.72 Million - $3.53 Million
7,734 Added 528.64%
9,197 $3.87 Million
Q3 2022

Nov 14, 2022
SELL
$412.59 - $563.26 $555,346 - $758,147
-1,346 Reduced 47.92%
1,463 $610,000
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $2.39 Million - $3.07 Million
-5,147 Reduced 64.69%
2,809 $1.39 Million
Q1 2022

May 16, 2022
BUY
$524.57 - $735.42 $918,522 - $1.29 Million
1,751 Added 28.22%
7,956 $4.48 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $1.1 Million - $1.23 Million
-1,550 Reduced 19.99%
6,205 $4.69 Million
Q3 2021

Nov 15, 2021
BUY
$657.71 - $825.77 $716,246 - $899,263
1,089 Added 16.34%
7,755 $5.79 Million
Q2 2021

Aug 11, 2021
BUY
$576.64 - $649.04 $1.78 Million - $2.01 Million
3,091 Added 86.46%
6,666 $4.3 Million
Q1 2021

May 17, 2021
SELL
$547.01 - $662.35 $2.32 Million - $2.81 Million
-4,244 Reduced 54.28%
3,575 $2.04 Million
Q4 2020

Feb 16, 2021
BUY
$510.68 - $643.45 $2 Million - $2.52 Million
3,924 Added 100.74%
7,819 $4.56 Million
Q2 2020

Aug 14, 2020
SELL
$334.87 - $493.06 $2.72 Million - $4 Million
-8,111 Reduced 67.56%
3,895 $1.76 Million
Q1 2020

May 15, 2020
SELL
$320.01 - $409.07 $1.01 Million - $1.29 Million
-3,151 Reduced 20.79%
12,006 $4.21 Million
Q4 2019

Feb 14, 2020
BUY
$319.73 - $374.2 $4.34 Million - $5.08 Million
13,566 Added 852.67%
15,157 $5.61 Million
Q3 2019

Nov 14, 2019
SELL
$304.55 - $345.24 $16 Million - $18.2 Million
-52,611 Reduced 97.06%
1,591 $529,000
Q2 2019

Aug 16, 2019
BUY
$286.93 - $312.59 $358,949 - $391,050
1,251 Added 2.36%
54,202 $16.9 Million
Q2 2019

Aug 14, 2019
BUY
$286.93 - $312.59 $14.2 Million - $15.5 Million
49,530 Added 1447.82%
52,951 $16.6 Million
Q3 2018

Nov 14, 2018
BUY
$289.28 - $326.15 $510,579 - $575,654
1,765 Added 106.58%
3,421 $1.07 Million
Q2 2018

Aug 14, 2018
BUY
$244.1 - $303.88 $404,229 - $503,225
1,656 New
1,656 $478,000

Others Institutions Holding BIO

# of Institutions
427
Shares Held
19.1M
Call Options Held
10.7K
Put Options Held
35.5K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.33B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email